Impact of surgical resection of liver metastases on outcome of patients with KRAS-wildtype exon 2 (KRAS-wt) metastatic colorectal carcinoma (mCRC) treated with a cetuximab-based first-line therapy - Interim analysis of the German non-interventional study ERBITAG

Neumann, U.; Goehler, T.; Hering-Schubert, C.; Janssen, J.; Sahm, S.; Schwittay, M.; Zahn, M. O.; Stenzel, K. G.; Overkamp, F.

oai:publications.rwth-aachen.de:686632

Impact of surgical resection of liver metastases on outcome of patients with KRAS-wildtype exon 2 (KRAS-wt) metastatic colorectal carcinoma (mCRC) treated with a cetuximab-based first-line therapy - Interim analysis of the German non-interventional study ERBITAG

Authors: U. Neumann
T. Goehler
C. Hering-Schubert
J. Janssen
S. Sahm
M. Schwittay
M. O. Zahn
K. G. Stenzel
F. Overkamp
Publication date: 1 January 2016
Publisher: 'Oxford University Press (OUP)'
Doi

Abstract

Abstract is not available.

Similar works

Full text

Publikationsserver der RWTH Aachen University

oai:publications.rwth-aachen.d...

Last time updated on 04/11/2017

This paper was published in Publikationsserver der RWTH Aachen University.

Having an issue?

Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.